Patents by Inventor Nathan Lazar

Nathan Lazar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230386632
    Abstract: Methods and systems for evaluating a query perturbation, in a cell based assay representing a test state, are provided. Control data points having dimensions representing measurements of different features across control cell aliquots are obtained. Test data points having dimensions representing measurements of different features across test cell aliquots are obtained. A composite test vector is computed between measures of central tendency across the control data points and measures of central tendency across the test data points. Query perturbation data points having dimensions representing measurements of different features across perturbation cell aliquots are obtained. A composite query perturbation vector is computed between measures of central tendency across the control data points and measures of central tendency across the plurality of query perturbation data points.
    Type: Application
    Filed: July 27, 2023
    Publication date: November 30, 2023
    Applicant: Recursion Pharmaceuticals, Inc.
    Inventors: Mason Victors, Berton Earnshaw, Renat Khaliullin, Blake Borgeson, Peter McLean, Nathan Lazar, Katie-Rose Skelly
  • Patent number: 11715551
    Abstract: Methods and systems for evaluating a query perturbation, in a cell based assay representing a test state, are provided. Control data points having dimensions representing measurements of different features across control cell aliquots are obtained. Test data points having dimensions representing measurements of different features across test cell aliquots are obtained. A composite test vector is computed between measures of central tendency across the control data points and measures of central tendency across the test data points. Query perturbation data points having dimensions representing measurements of different features across perturbation cell aliquots are obtained. A composite query perturbation vector is computed between measures of central tendency across the control data points and measures of central tendency across the plurality of query perturbation data points.
    Type: Grant
    Filed: June 18, 2020
    Date of Patent: August 1, 2023
    Inventors: Mason Victors, Berton Earnshaw, Renat Khaliullin, Blake Borgeson, Peter McLean, Nathan Lazar, Katie-Rose Skelly
  • Publication number: 20220262455
    Abstract: A system for determining a goodness of a deep learning model comprises a memory coupled with a processor. The processor accesses a first set of vectors representative of images of a biological assay. The vectors of the first set of vectors are outputs of a first deep learning model. The processor creates a first distribution of a first plurality of pairwise comparisons of vectors, of the first set of vectors, which were generated from image pairs with similar cell perturbations. The processor creates a second distribution of a second plurality of pairwise comparisons of vectors, of the first set of vectors, which were generated from image pairs with dissimilar cell perturbations. The processor determines a difference between the first distribution and the second distribution and uses the difference to make a determination of goodness of the deep learning model as applied to the biological assay.
    Type: Application
    Filed: February 18, 2021
    Publication date: August 18, 2022
    Applicant: Recursion Pharmaceuticals, Inc.
    Inventors: Berton EARNSHAW, James JENSEN, Renat KHALIULLIN, Nathan LAZAR
  • Publication number: 20220238181
    Abstract: A system for selecting CRISPR guides for knocking out one or more target genes in a target cell from a multiplicity of candidate guides comprises a memory and a processor. The processor determines whether the candidate guide meets a plurality of thresholds. The thresholds are associated with: a transcript support level; targeting a consensus sequence of a target gene; which exon of the target gene is targeted; targeting of a primary transcript, targeting of a common isoform; a precomputed prediction of editing outcomes; mapping to an expressed sequence; fraction of gene expression attributable to targeted transcripts; a common SNP overlap threshold; which exon of the target gene is targeted; overlap of a selected guide; predicted frameshift percentage; maximum and minimum GC content; off target score; where a coding sequence is targeted. In response to meeting the thresholds, the processor selects the candidate guide as a selected CRISPR guide.
    Type: Application
    Filed: January 27, 2022
    Publication date: July 28, 2022
    Applicant: Recursion Pharmaceuticals, Inc.
    Inventors: James JENSEN, Timothy DAHLEM, Sarah HUGO, Jacob COOPER, Spencer SCHREIER, Ian QUIGLEY, Imran HAQUE, Nathan LAZAR, Alison GARDNER, Ben BANOWSKY, August ALLEN
  • Publication number: 20200402628
    Abstract: Methods and systems for evaluating a query perturbation, in a cell based assay representing a test state, are provided. Control data points having dimensions representing measurements of different features across control cell aliquots are obtained. Test data points having dimensions representing measurements of different features across test cell aliquots are obtained. A composite test vector is computed between measures of central tendency across the control data points and measures of central tendency across the test data points. Query perturbation data points having dimensions representing measurements of different features across perturbation cell aliquots are obtained. A composite query perturbation vector is computed between measures of central tendency across the control data points and measures of central tendency across the plurality of query perturbation data points.
    Type: Application
    Filed: June 18, 2020
    Publication date: December 24, 2020
    Applicant: Recursion Pharmaceuticals, Inc.
    Inventors: Mason Victors, Berton Earnshaw, Renat Khaliullin, Blake Borgeson, Peter McLean, Nathan Lazar, Katie-Rose Skelly